Naohiko Nakanishi Selected Research

Naohiko Nakanishi Research Topics

Disease

6	Neoplasms (Cancer) 04/2024 - 11/2019
6	Pulmonary Hypertension 01/2024 - 04/2015
5	Hemorrhage 04/2024 - 04/2019
4	Venous Thrombosis (Deep-Vein Thrombosis) 04/2024 - 11/2019
3	Venous Thromboembolism 04/2024 - 11/2019
3	Hypoxia (Hypoxemia) 06/2023 - 04/2015
3	Cardiomegaly (Heart Hypertrophy) 01/2019 - 03/2010
3	Cardiomyopathies (Cardiomyopathy) 01/2017 - 12/2015
2	Pulmonary Embolism 03/2024 - 11/2020
2	Pulmonary Arterial Hypertension 12/2023 - 01/2016
2	Heart Failure 10/2023 - 03/2010
2	Thrombosis (Thrombus) 11/2020 - 11/2019
2	Myocardial Infarction 05/2019 - 10/2017
2	Hematoma 04/2019 - 12/2009
2	False Aneurysm (Pseudoaneurysm) 04/2019 - 09/2007
2	Hypertrophy 01/2016 - 03/2014
1	Fibrosis (Cirrhosis) 10/2023
1	Obesity 01/2022
1	COVID-19 01/2021
1	Infections 01/2021
1	Splenic Infarction 11/2020
1	Pathologic Constriction (Stenosis) 11/2020
1	Hyperhomocysteinemia 11/2020
1	Acute Coronary Syndrome 11/2020
1	No-Reflow Phenomenon 11/2020
1	Essential Thrombocythemia 05/2019
1	Blood Vessel Dissection 04/2019
1	Arteriovenous Fistula 04/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Infarction (Infarctions) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	ST Elevation Myocardial Infarction 10/2017
1	Hearing Loss (Hearing Impairment) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Atrial Fibrillation 01/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2013
1	Metabolic Diseases (Metabolic Disease) 03/2013
1	Inflammation (Inflammations) 03/2013
1	Ventricular Tachycardia 04/2011
1	Heart Arrest (Cardiac Arrest) 04/2011
1	Ventricular Fibrillation 04/2011
1	Hypertension (High Blood Pressure) 03/2010
1	Rupture 12/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2014
3	edoxabanIBA 04/2024 - 11/2023
3	RivaroxabanIBA 03/2024 - 11/2019
3	AnticoagulantsIBA 12/2022 - 11/2019
2	Caveolin 1IBA 01/2024 - 01/2016
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2016
2	Caveolin 3IBA 01/2016 - 12/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023
1	AerosolsIBA 01/2021
1	LipidsIBA 11/2020
1	Troponin IIBA 11/2020
1	CreatinineIBA 11/2019
1	Early Growth Response Protein 1IBA 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	CaveolinsIBA 12/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2015
1	Focal Adhesion Kinase 2IBA 04/2015
1	AdipokinesIBA 03/2013
1	Endoplasmic Reticulum Chaperone BiPIBA 03/2010
1	SaltsIBA 03/2010
1	Amyloid (Amyloid Fibrils)IBA 12/2009
1	Polytetrafluoroethylene (Teflon)FDA Link 09/2007

Therapy/Procedure

6	Therapeutics 04/2024 - 11/2019
3	Stents 11/2020 - 09/2007
3	Percutaneous Coronary Intervention 11/2020 - 10/2017
2	Catheters 01/2023 - 11/2020
2	Endarterectomy (Thromboendarterectomy) 01/2023 - 01/2023
1	Drug Tapering 12/2022
1	Personal Protective Equipment 01/2021
1	Thrombolytic Therapy 11/2019
1	Punctures 04/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Catheter Ablation 01/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2013
1	Cardiopulmonary Resuscitation (CPR) 04/2011